Hovinga K - Search Results

1

LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas.

Vanderheijden C, Vaessen T, Yakkioui Y, Riedl R, Temel Y, Hovinga K, Hoogland G. Vanderheijden C, et al. Among authors: hovinga k. J Neurooncol. 2022 May;158(1):81-88. doi: 10.1007/s11060-022-04012-9. Epub 2022 May 4. J Neurooncol. 2022. PMID: 35507100 Free PMC article.

2

Therapy of Sporadic and NF2-Related Vestibular Schwannoma.

Yao L, Alahmari M, Temel Y, Hovinga K. Yao L, et al. Among authors: hovinga k. Cancers (Basel). 2020 Mar 31;12(4):835. doi: 10.3390/cancers12040835. Cancers (Basel). 2020. PMID: 32244314 Free PMC article. Review.

3

Neurofibromatosis.

Hovinga KE, Temel Y. Hovinga KE, et al. Cancers (Basel). 2020 Oct 2;12(10):2851. doi: 10.3390/cancers12102851. Cancers (Basel). 2020. PMID: 33023148 Free PMC article.

4

Genes Predicting Survival of Chordoma Patients.

Vanderheijden C, Vaessen T, Yakkioui Y, Temel Y, Hoogland G, Hovinga K. Vanderheijden C, et al. Among authors: hovinga k. World Neurosurg. 2021 Dec;156:125-132. doi: 10.1016/j.wneu.2021.09.027. Epub 2021 Sep 13. World Neurosurg. 2021. PMID: 34530149 Free article. Review.

5

A rare complication after vestibular schwannoma surgery: Neurogenic pulmonary edema.

Ravindran PK, Kunst D, Waterval J, Hovinga K, Temel Y. Ravindran PK, et al. Among authors: hovinga k. Surg Neurol Int. 2022 Sep 30;13:441. doi: 10.25259/SNI_277_2022. eCollection 2022. Surg Neurol Int. 2022. PMID: 36324918 Free PMC article.

6

Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study.

Regli LKP, Huijs SMH, Pasmans RCOS, Leue C, Dijkstra JB, Eekers DBP, Hovinga KE, Anten MHME, Hoeben A, Broen MPG. Regli LKP, et al. Among authors: hovinga ke. J Neurooncol. 2023 May;163(1):185-194. doi: 10.1007/s11060-023-04326-2. Epub 2023 May 10. J Neurooncol. 2023. PMID: 37162667 Free PMC article.

7

Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma.

van Linde ME, van der Mijn JC, Pham TV, Knol JC, Wedekind LE, Hovinga KE, Aliaga ES, Buter J, Jimenez CR, Reijneveld JC, Verheul HM. van Linde ME, et al. J Neurooncol. 2016 Sep;129(2):221-30. doi: 10.1007/s11060-016-2178-x. Epub 2016 Jul 21. J Neurooncol. 2016. PMID: 27444431 Free PMC article.

8

EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma.

Hovinga KE, McCrea HJ, Brennan C, Huse J, Zheng J, Esquenazi Y, Panageas KS, Tabar V. Hovinga KE, et al. J Neurooncol. 2019 Apr;142(2):337-345. doi: 10.1007/s11060-019-03102-5. Epub 2019 Jan 24. J Neurooncol. 2019. PMID: 30680510 Free PMC article.

9

Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain.

Zegers CML, Offermann C, Dijkstra J, Compter I, Hoebers FJP, de Ruysscher D, Anten MM, Broen MPG, Postma AA, Hoeben A, Hovinga KE, Van Elmpt W, Eekers DBP. Zegers CML, et al. Among authors: hovinga ke. Clin Transl Radiat Oncol. 2023 Jul 22;42:100664. doi: 10.1016/j.ctro.2023.100664. eCollection 2023 Sep. Clin Transl Radiat Oncol. 2023. PMID: 37576068 Free PMC article.

10

Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines--a clue to radioresistance?

Hovinga KE, Stalpers LJ, van Bree C, Donker M, Verhoeff JJ, Rodermond HM, Bosch DA, van Furth WR. Hovinga KE, et al. J Neurooncol. 2005 Sep;74(2):99-103. doi: 10.1007/s11060-004-4204-7. J Neurooncol. 2005. PMID: 16193379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page